The SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTervention for Cardiometabolic Health) Trial
NCT06907862 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2026-05-04
Summary
This is a randomized, controlled, parallel study with 3 experimental arms aimed to assess the effect of a digital dietary intervention (web-based app, online behavior change curriculum) enhanced with 10 servings of vegetables and fruit (5 as dietary advice within the app, 5 within a dehydrated vegetable and fruit blend), with or without high Ultra Processed Food (UPF) soy-containing proteins compared to standard of care (usual care) on systolic blood pressure (SBP; primary outcome), and other key cardiometabolic endpoints over 12-weeks in adults living with hypertension and obesity, 50% with type 2 diabetes. The main questions this study aims to answer are:
1. Are nutrient-dense, high-UPF soy-protein foods similar (non-inferior) to low-UPF soy-protein foods in the context of a guidelines-based diet in their effect on blood pressure and other cardiometabolic risk factors?
2. Does an enhanced digital dietary intervention lead to meaningful reductions in blood pressure and other cardiometabolic risk factors compared to standard of care?
Participants who are eligible and consent to be part of this study will be randomized to one of the following groups: 1) Active treatment (high-UPF soy-containing enhanced digital dietary intervention), 2) Reference treatment (low-UPF soy-containing enhanced digital dietary intervention), or 3) Control (standard of care).
Participant Requirements:
During the 12-week intervention, all participants will be required to attend in-person clinic visits at baseline (week 0), week 8 and 12.
Baseline Visit (Week 0): Participants will be asked to arrive in a fasted state (no food or beverages, except water, for 10-12 hours before the visit).
* Undergo various assessments, including anthropometric measurements, office blood pressure readings, and blood sampling (via a capillary finger prick and blood sample taken by the study nurse).
* Review the 7-day food records completed using the Keenoa mobile app one week prior to clinic visit.
* Bring fecal and urine samples from home.
* Complete and review all questionnaires received via email one week prior.
Telephone Check-in (Week 1):
One week after beginning the study, the study staff will call participants to check in on how participants are following the protocol and answer any questions.
Mid-Study Visit (Week 8): Participants will be asked to arrive in a fasted state (no food or beverages, except water, for 10-12 hours before the visit).
* Have their office blood pressure and anthropometric measurements taken.
* Complete and review all questionnaires received via email one week prior
* Review the 3-day food records completed using the Keenoa mobile app one week prior to clinic visit.
Final Study Visit (Week 12): Participants will be asked to arrive in a fasted state (no food or beverages, except water, for 10-12 hours before the visit).
* Undergo various assessments, including anthropometric measurements, office blood pressure readings, and blood sampling (via a capillary finger prick and blood sample taken by the study nurse).
* Review the 7-day food records completed using the Keenoa mobile app one week prior to clinic visit.
* Bring fecal and urine samples from home.
* Complete and review all questionnaires received via email one week prior.
Throughout the study, participants will be asked to continue their usual lifestyle and physical activity.
Additional Requirements for Treatment Groups:
Participants randomized to the active and reference treatment groups will also be required to:
* Incorporate a study vegetable and fruit blend (provided) into their daily diet for the full 12 weeks
* Consume soy products categorized as either high ultra processed soy foods at least 4 servings per day, including at least 2 servings of ultra processed soy milk and 2 servings of other soy-based products (e.g., soy yogurt, soy burgers, or soy ground round) or non-ultra processed soy foods at least 4 servings per day, including at least 2 servings of minimally processed soy milk, 1 serving of edamame or roasted soy nuts, and 1 serving of tofu or tempeh
* Participate in the digital dietary intervention, which includes: a health app, 7-day Kickstart Package, weekly text message support, and a 7-session online interactive program designed based on behaviour change theory
* Attend a virtual focus group at Week 4 and complete an online feedback questionnaire
Conditions
- Hypertension in Type 2 Diabetes
- Diabetes Mellitus Type 2
- Dyslipidemia
- Hypertension
- Metabolic Health
- Cardiovascular Risk Factors
Interventions
- OTHER
-
Reference Treatment
≥4 servings/day of soy products categorized as non-ultra processed according to the NOVA classification system (NOVA non-Group 4): ≥2 servings/day of a Group 1 soy milk and ≥1 serving/day of another Group 1 food, such as edamame or roasted soy nuts, and ≥1 serving/day of a Group 3 food, such as tofu or tempeh) as part of a digital dietary intervention, enhanced with 10 servings of vegetables and fruit (5 as dietary advice and 5 provided in a blend of dehydrated vegetables and fruit)
- OTHER
-
Control
Usual care provided by their primary care physician and/or specialist.
- OTHER
-
Active Treatment
≥4 servings/day of soy products categorized as ultra processed according to the NOVA classification system (NOVA Group 4): ≥2 servings/day of soy milk and ≥2 servings/day of other soy-based products such as soy yogurt, soy burgers, or soy ground round) as part of a digital dietary intervention, enhanced with 10 servings of vegetables and fruit (5 as dietary advice and 5 provided in a blend of dehydrated vegetables and fruit)
Sponsors & Collaborators
-
University of Toronto
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-06
- Primary Completion
- 2027-06-30
- Completion
- 2028-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Meta-analysis of 46 FDA Identified Studies on Lipid Markers
NCT03468127 ·Status: UNKNOWN
-
Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction
NCT04861545 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance
NCT02380963 ·Status: COMPLETED ·Phase: NA
-
Impact of Ultra-processed Foods on Cardiometabolic Risk Factors
NCT06538831 ·Status: RECRUITING ·Phase: NA
-
Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance
NCT03248804 ·Status: COMPLETED ·Phase: NA
-
Barley Protein and CVD
NCT00334308 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
NCT03429920 ·Status: COMPLETED ·Phase: NA
-
Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance
NCT05337007 ·Status: COMPLETED ·Phase: NA
-
Whole Soy Replacement Diet on Metabolic Features
NCT02610322 ·Status: UNKNOWN ·Phase: NA
-
Impacts of Fermented Pea- and Legume-based Product on Gut Microbiota and Health
NCT06743828 ·Status: COMPLETED ·Phase: NA
-
Effect of Ultra Processed Versus Unprocessed Diets on Energy Intake
NCT03407053 ·Status: COMPLETED ·Phase: NA
-
A Human Trial to Assess the Low Density Lipoprotein Cholesterol (LDL-C) Lowering Effect of Soy
NCT01547585 ·Status: COMPLETED ·Phase: NA
-
Acute Vascular Response To Meals Varying In Glycemic Index And Glycemic Load
NCT01883700 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Dairy and Non-dairy Breakfasts on Satiety and Post-meal Glycemia in Healthy Older Adults
NCT02607007 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Soybean Oil Trial of cArdiovascular Risk
NCT02404207 ·Status: COMPLETED ·Phase: NA
-
Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome
NCT01010841 ·Status: COMPLETED ·Phase: NA
-
Fermented Plant-based Portfolio Diet 4 Metabolic Health
NCT06587958 ·Status: COMPLETED ·Phase: NA
-
Effect of Peas in Soup on Blood Glucose Control
NCT03306862 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Potato Fries Processing on Food Intake, Satiety and Blood Glucose
NCT02014207 ·Status: COMPLETED ·Phase: NA
-
Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health
NCT06749327 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dietary Guidelines for Americans-Ultra Processed Study
NCT07252037 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of the Inclusion of Soybean Flour on Glycemic Responses
NCT06280625 ·Status: TERMINATED ·Phase: NA
-
Validating the "Foods for Health" Portfolio of Functional Food Products
NCT02341924 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia
NCT02924558 ·Status: COMPLETED ·Phase: NA
-
SWAP-MEAT Athlete: Three Diets on Athletic Performance
NCT05472701 ·Status: COMPLETED ·Phase: NA